Search results
Order by most recent / most popular / relevance
Results: 1-4 of 4
Competition Bureau reaches agreement in TevaRatiopharm merger
- Stikeman Elliott LLP
- -
- Canada
- -
- August 25 2010
On July 30, 2010, the Competition Bureau (Bureau) announced that it had reached a consent agreement with Teva Pharmaceuticals Industries Ltd. (Teva) and the Merckle Group, carrying on business as ratiopharm, requiring the divestiture of assets and associated licenses in relation to certain forms of acetaminophen oxycodone tablets and morphine sulfate sustained release tablets
Akzo Nobel fined $3.15 million for price fixing
- Stikeman Elliott LLP
- -
- Canada
- -
- November 24 2008
Canada's Competition Bureau announced on November 21, 2008 that Akzo Nobel Chemicals International BV had pled guilty to criminal charges for fixing the price of hydrogen peroxide sold in Canada between 1998 and 2001, and agreed to pay a C$3
Health and environmental claims an ongoing bureau focus
- Stikeman Elliott LLP
- -
- Canada
- -
- December 18 2007
Investigations and enforcement actions over marketing and advertising claims related to health products and services have been a significant part of the Bureau's recent fair-business-practices work
Bureau releases generic drug sector study
- Stikeman Elliott LLP
- -
- Canada
- -
- November 15 2007
On October 29, 2007 the Competition Bureau (the Bureau) released its Canadian Generic Drug Sector Study, initiated in September, 2006, to identify areas where changes in the market framework might attain greater benefits through competition
